|
Tansy
In The News
First
appeared: Saturday, February
26, 2011
You might have seen the global
news coverage of our recent
research findings on Tansy. As
hundreds of news articles all over
the world have picked up the
story, we are obliged to put this
information page to answer
the large volume of questions put
forward to us by the public
and the media.
...See
the media coverage of our
findings...
Tansy
| Tansy
is a common name for a
herbaceous perennial
plant known by its
scientific name as
Tanacetum
vulgare. The
plant belongs to
the family
Asteraceae and
distributed throughout
temperate Europe and
Asia where it grows
along roadsides,
hedgerows and waste
places. Among the many
traditional medicinal
uses of Tansy reported
in the current
literature are those
related to skin
eruptions and related
conditions. While many
scientific
reports
published in recent
years have shown the
promise of Tansy for
some disease
conditions, several
areas of outstanding
scientific
researches are
yet to be addressed
to validate the claimed
traditional uses. |
 |
Our
Research On Tansy
Our (Dr Habtemariam's) research
interest focus on the
pharmacological and phytochemical
evaluations of medicinal plants.
During the past two decades, our
research group has provided
scientific evidence for medicinal
uses of various European medicinal
plants. Our research group
has also assisted many
herbal medicine practitioners,
suppliers and consumers who wished
to ascertain the quality of
their crude herbal products. As
part of this ongoing effort to
modernise traditional herbal
medicines, Tansy has been included
in our research projects. First we
have shown that extracts obtained
from the aerial parts of
Tansy possess potent antioxidant
properties; an effect which is of
interest to wound healing
properties. We have further
identified the active principles
of the antioxidant compounds -
these results are published in a
scientific journal: Natural
Product Communications, Volume
4, Number 11, Page No. 1561 -
1564. In view of
this finding, a comprehensive
research on antiherpes activity
study became very relevant.
Herpes
Two forms of
herpes simplex viruses (HSV-1
and HSV-2) are known to cause
long-term latent infections with
periods of recurring viral
replication. The common sites of
infection are the lips, eyes,
mucous membrane of the oral
cavity and the genitals.
Incidence of herpes especially
HSV-2 that causes genital
infection has been
steadily increasing in recent
years. The ever increasing
incidences of drug
resistance together with
immunosuppressive illnesses such
as AIDS have been the major
problems associated with the
growing prevalence of the
disease. As recently reported in
ScienceDaily (Sep. 30, 2010),
experimental vaccines intended
to prevent herpes has not proven
to be effective. A novel
drug which addresses the above
mentioned problems are therefore
a long awaited blessing.
Our UK-Spanish
Collaboration
In 2009, our
(Dr Habtemariam's) research
group has forged a research link
with Professor Francisco Parra
(Universidad de Oviedo
Spain). Our studies included the
bioassay of crude extracts of
the aerial parts of Tansy as
well as the underground
rhizomatous parts. We have also
included several fractions and
isolated compounds
including parthenolide
which has previously
been reported for its
antiviral activities. We have
shown that, compounds other than
parthenolide were responsible
for the antiviral activities and
our results were published in a
scientific journal:
Phytotherapy Research, Volume
25, Number
2, pages 296-301. We are
currently undergoing further
research on the chemistry and
pharmacology of Tansy extracts
and purified compounds.
We
are currently running
various other collaborative
projects and work closely with
colleagues in Africa,
Australia, India, Europe and
North America. Our research
projects cover a wide range of
disease conditions and
we always welcome a
collaborative research call
from interested groups in this
field.
...See the media coverage of our findings...
Home
.................We value
your feedback..................
FOLLOW US ALSO ON THE
FOLLOWING:

|